Myocardial Infarction Revealing an Antiphospholipid Syndrome in a 27-Year-Old Woman;Infarctus du Myocarde Révélant un Syndrome des Antiphospholipides Chez une Jeune Femme de 27 Ans

Archives des Maladies du Coeur et des Vaisseaux

Volumn 96, Issue 12, 2003, Pages 1231-1234

  Baudouy, Ph Y ^a   Bouchachi, A A ^a   Costedoat Chalumeau, N ^b   Eiferman, Ch ^a   Abassade, Ph ^a   Lhosmot, J P ^a   Ricard, G ^a   Piette, J Ch ^b  

^a Hopital Saint Michel   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLIPIN ANTIBODY;

ACUTE HEART INFARCTION; ADULT; ANGIOCARDIOGRAPHY; ANTIPHOSPHOLIPID SYNDROME; ARTERY THROMBOSIS; ARTICLE; CASE REPORT; CONNECTIVE TISSUE DISEASE; CORONARY STENT; FEMALE; FOLLOW UP; HEART VENTRICLE; HUMAN; SMOKING; TRANSLUMINAL CORONARY ANGIOPLASTY;

ADULT; ANTIPHOSPHOLIPID SYNDROME; FEMALE; HUMANS; MYOCARDIAL INFARCTION;

EID: 1542299179     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Cervera R, Piette JC, Font J et al. Antiphospholipid syndrome: clinical and immunological manifestations and patterns of disease expression in a cohort of 1000 patients. Arthritis Rheum 2002; 46: 1019-27.
2. Wilson WA, Gharavi AE, Koike T et al. International consensus statement on preliminary classification for definite antiphospholipid syndrome. Arthritis Rheum 1999; 43: 1309-11.
3. Petri M. Epidemiology of the antiphospholipid antibody syndrome. J Autoimmun 2000; 15: 145-51.
4. Vaarala O, Manttari M, Manninen V et al. Anti-cardiolipin antibodies and risk of myocardial infarction in prospective cohort of middle-aged men. Circulation 1995; 91: 23-7.
5. Kattwinkel N, Villanueva AG, Labib SB et al. Myocardial infarction caused by cardiac microvasculopathy in a patient with the primary antiphospholipid syndrome. Ann Intern Med 1992; 116: 974-6.
6. Philippe P, Charmion S, Citron B et al. Antiprothrombinase et infarctus du myocarde. À propos de deux observations. Rev Med Interne 1990; 11: 154-6.
7. Derumeaux G, Lenormand C, Borg JY, Lévesque H, Tron F, Letac B. Prévalence et description des atteintes cardiaques dans le syndrome primaire des antiphospholipides. Arch Mal Cœur 1992; 85: 1811-8.
8. Rosove MH, Brewer PMC. Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients. Ann Intern Med 1992; 117: 303-8.
9. Dacosta A, Guy JM, Rousset H et al. Infarctus indolore au cours du syndrome des antiphospholipides. Arch Mal Cœur 1993; 86: 1773-5.
10. Takeuchi S, Obayashi T, Toyama J. Primary antiphospholipid syndrome with acute myocardial infarction recanalised by PTCA. Heart 1998; 79: 96-8.
11. Badak O, Guneri S, Kirimli O, Goldeli O, Aslan O, Ozsan H. Primary stenting in a patient with acute myocardial infarction and primary antiphospholipid syndrome. J Invasive Cardiol 2002; 14: 194-7.
12. Wahl DG, Bounameaux H, de Moerloose P, Sarasin FP. Prophylactic antithrombic therapy for patients with systemic lupus erythematosus with or without antiphospholipid antibodies: do the benefits outweigh the risks? A decision analysis. Arch Intern Med 2000; 160: 2042-8.